Assessing acute myeloid leukemia susceptibility in rearrangement‐driven patients by DNA breakage at topoisomerase II and CCCTC‐binding factor/cohesin binding sites-Reference-Cited by-同舟云学术

Assessing acute myeloid leukemia susceptibility in rearrangement‐driven patients by DNA breakage at topoisomerase II and CCCTC‐binding factor/cohesin binding sites

Published:2021-08-26 Issue:12 Volume:60 Page:808-821
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Atkin Naomi D.¹^ORCID,Raimer Heather M.¹^ORCID,Wang Zhenjia²,Zang Chongzhi¹²³,Wang Yuh‐Hwa¹^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Genetics University of Virginia School of Medicine Charlottesville Virginia USA

2. Center for Public Health Genomics University of Virginia School of Medicine Charlottesville Virginia USA

3. Department of Public Health Sciences University of Virginia School of Medicine Charlottesville Virginia USA

Funder

National Cancer Institute

National Institute of General Medical Sciences

Publisher

Wiley

Subject

Cancer Research,Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/gcc.22993

Reference70 articles.

1. Repair Pathway Choices and Consequences at the Double-Strand Break

2. Common fragile sites as targets for chromosome rearrangements

3. DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells

4. Mutation-associated fusion cancer genes in solid tumors

5. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3C methods in cancer research: recent advances and future prospects;Experimental & Molecular Medicine;2024-04-25

2. DNA fragility at topologically associated domain boundaries is promoted by alternative DNA secondary structure and topoisomerase II activity;Nucleic Acids Research;2024-03-07

3. Epigenetic balance ensures mechanistic control of MLL amplification and rearrangement;Cell;2023-10

4. 3D chromatin architecture and transcription regulation in cancer;Journal of Hematology & Oncology;2022-05-04